Lipid Biomarker Research in Bipolar Disorder: A Scoping Review of Trends, Challenges, and Future Directions
Biological Psychiatry Global Open Science · 2023-10 · 3 (4) · 594-604
DOI: 10.1016/j.bpsgos.2023.07.004 ↗Kurz gefasst
Scoping Review in der Zeitschrift Biological Psychiatry Global Open Science, 2023-10. Verfasst von John Kim Hiller und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Oslo, Oslo, Norway. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medisinske fakultet, Universitetet i Oslo.
Abstract (Originalsprache)
Bipolar disorder (BD) is a disabling disorder with heterogeneous symptom profiles and trajectories. Like many other neuropsychiatric disorders, clinical decision making related to diagnoses and choice of treatment is based on clinical assessments alone, and risk prediction for treatment success or resistance at an individual level remains sparse. An enormous effort to add biological markers to this risk prediction is ongoing. The role of lipids in normal brain functioning is well established, and several hypotheses about the role of lipids in the pathogenesis of neuropsychiatric disorders, including BD, have been made. The frequent comorbidity between neuropsychiatric disorders and cardiovascular disease, the genetic overlap of risk genes for severe mental disorders and genes involved in lipid regulation, and the lipid-altering effects of antipsychotics and mood stabilizers indicate that lipids could hold promise as biomarkers for neuropsychiatric disorders, including BD. To date, reviews of lipid biomarkers in schizophrenia and major depression have noted caveats for future investigations, while reviews of lipid biomarker research in BD is missing. In the current scoping review, we present a comprehensive overview of trends in previous research on lipid biomarkers in BD. The current literature varies greatly in the phenotypes investigated and study designs, leading to divergent findings. Small sample size; potential confounders related to physical activity, nutritional status, and medication use; and cross-sectional designs were frequently reported limitations. Future research may benefit from pivoting toward utilization of newer laboratory techniques such as lipidomics, but consistent use of study methods across cohorts is also needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
- Centre for Research and Education in Forensic Psychiatry, Department of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
- Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Förderung
- Medisinske fakultet, Universitetet i Oslo
Zitieren
APA
Hiller, J. K., Jangmo, A., Tesli, M. S., Jaholkowski, P. P., Hoseth, E. Z., Steen, N. E., & Haram, M. (2023). Lipid Biomarker Research in Bipolar Disorder: A Scoping Review of Trends, Challenges, and Future Directions. Biological Psychiatry Global Open Science, 3(4), 594-604. https://doi.org/10.1016/j.bpsgos.2023.07.004
Vancouver
Hiller JK, Jangmo A, Tesli MS, Jaholkowski PP, Hoseth EZ, Steen NE, et al. Lipid Biomarker Research in Bipolar Disorder: A Scoping Review of Trends, Challenges, and Future Directions. Biological Psychiatry Global Open Science. 2023;3(4):594-604. doi:10.1016/j.bpsgos.2023.07.004
BibTeX
@article{Hiller2023,
author = {Hiller, John Kim and Jangmo, Andreas and Tesli, Martin Steen and Jaholkowski, Piotr Pawel and Hoseth, Eva Zsuzsanna and Steen, Nils Eiel and Haram, Marit},
title = {Lipid Biomarker Research in Bipolar Disorder: A Scoping Review of Trends, Challenges, and Future Directions},
journal = {Biological Psychiatry Global Open Science},
year = {2023},
volume = {3},
number = {4},
pages = {594--604},
doi = {10.1016/j.bpsgos.2023.07.004}
}
EUVIMED